About Novalar Pharm
Novalar Pharm is a Healthcare company based in Manchester (United Kingdom) founded in 2000. Online pharmacy store. Novalar Pharm has raised $53.23 million across 5 funding rounds from investors including NEA, Domain Associates and SR One. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its legal entity is NOVALAR (UK) LIMITED. Its competitors include Pharmacy2U, LloydsDirect and Health & Her; 2 of its 3 listed competitors have raised funding.
Company details
Novalar Pharm was established in 2000 in Manchester, United Kingdom, within the pharmaceutical sector. Operations are conducted as an online pharmacy, where a range of medicines is distributed across categories such as allergies, anti-infectives, diabetes, womens health, weight loss, and cardiovascular diseases. The platform serves customers digitally, with oversight from executives including CFO Robert Steven Stefanovich. Services focus on accessible medication procurement without physical storefronts.
- Headquarters Manchester, United Kingdom
- SectorsHealthcare
- Phone•••• ••••
- Website novalarpharm.com
- Legal Name Novalar (Uk) Limited
- Date of Incorporation 27 Mar, 2009
- Jurisdiction ALLINGTON, MAIDSTONE, KENT
- Total Equity Funding$53.23M (USD)
in 5 rounds
- Latest Funding Round$1M (USD), Series D
Jul 2010
- InvestorsNEA
& 3 more
Funding Insights of Novalar Pharm
Novalar Pharm has successfully raised a total of $53.23M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $1 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $53.23M
- Total Rounds 5
- Last Round Series D — $1M
- First Round $4.17M
(Jun 2002)
- Investors Count 4
All 5 funding rounds of Novalar Pharm with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2010 | $1M | Series D | – | – | – |
| Nov 2007 | $30M | Series D | – | – | |
| Jan 2006 | $13M | Series C | – | – | – |
| Jun 2004 | $5.05M | Series B | – | – | – |
| Jun 2002 | $4.17M | Series A | – | – | – |
4 investors in total: 4 institutional.
Investors in Novalar Pharm
Novalar Pharm has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include NEA, Domain Associates and SR One.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are offered to startups by NEA. | nea.com | Menlo Park, United States | ||
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
A biotechnology venture capital firm investing in innovative science. | srone.com | |||
Growth capital investments are made in healthcare and fintech companies. | mepvc.com | San Francisco, United States |
Investor details for Novalar Pharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Novalar Pharm
1 people are tracked at Novalar Pharm (1 in leadership).
| Name | Role | Group |
|---|---|---|
Robert Steven Stefanovich | CFO | Leadership |
Complete people profiles for Novalar Pharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Novalar Pharm
3 dated milestones of Novalar Pharm across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Novalar Pharm is founded.
- Funding First funding round of $4.2M.
- Funding Latest funding round, Series D, of $1.0M.
Competitors of Novalar Pharm
Novalar Pharm has 3 listed competitors in our database, 2 of them funded. They include Pharmacy2U, LloydsDirect and Health & Her.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pharmacy2u.co.uk | 1999 | Leeds, United Kingdom | $313.25M | 400 | Online pharmacy and teleconsultation platform | |
| lloydsdirect.co.uk | 2015 | Perivale, United Kingdom | $11.47M | Prescription medicines are ordered and delivered via an online platform. | ||
| healthandher.com | 2017 | Cardiff, United Kingdom | 21 | Women's health products and symptom tracking tools are provided online. |
Detailed competitors of Novalar Pharm
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Novalar Pharm
Websites that share an audience with Novalar Pharm (novalarpharm.com).
Websites whose visitors overlap most with Novalar Pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
empowered.org | empowered.org | 100% | #2,005,955 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novalar Pharm
Complete news archive for Novalar Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novalar Pharm
Novalar Pharm was founded in 2000 and raised its 1st funding round 2 years after it was founded.
Novalar Pharm is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Novalar Pharm is a funded company, having raised a total of $53.23M across 5 funding rounds to date. The company's 1st funding round was a Series A of $4.17M, raised on Jun 2002.
Novalar Pharm was established in 2000 in Manchester, United Kingdom, within the pharmaceutical sector. Operations are conducted as an online pharmacy, where a range of medicines is distributed across categories such as allergies, anti-infectives, diabetes, womens health, weight loss, and cardiovascular diseases. The platform serves customers digitally, with oversight from executives including CFO Robert Steven Stefanovich. Services focus on accessible medication procurement without physical storefronts.
Novalar Pharm's top competitors include Pharmacy2U, Health & Her and LloydsDirect.
Novalar Pharm has 4 investors. Key investors include NEA, Domain Associates, SR One, and Montreux Equity Partners.
Novalar Pharm operates through Novalar (Uk) Limited.